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Background/objectives: Restricting energy intake for weight management in older adults has potential to
adversely affect nutritional status and result in impairment of an already compromised immune system.
Investigation of alternative strategies to combat adiposity and sustain lean muscle mass in older adults
are warranted to minimise the risk of developing chronic diseases. Long chain omega-3 polyunsaturated
fatty acids (LCn-3PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may
play an important role through their impact on increased fat oxidation and reduced inﬂammation. This
study aimed to examine the association between erythrocyte membrane LCn-3PUFA and anthropometric
measures in an older population.
Subjects/methods: A cross-sectional sample of older adults (n ¼ 620; age 65e95 years; 56.3% females)
from the Retirement Health and Lifestyle Study (RHLS) was analysed. Anthropometric measurements,
including height, weight, body mass index (BMI), waist (WC) and hip circumference (HC) were taken. The
fatty acid composition of erythrocyte membranes was analysed via gas chromatography (GC) to deter-
mine the omega-3 index (%EPA plus %DHA).
Results: An inverse association was detected between the omega-3 index and anthropometric measures,
BMI (r ¼ 0.076, p¼0.06), WC (r ¼ 0.118, p < 0.01) and waist-to-hip ratio (WHR; r ¼ 0.149, p < 0.001).
Stratiﬁcation of data by sex (females, n ¼ 349; males, n ¼ 271) indicated that these associations were sex-
speciﬁc. Females displayed an inverse association between the omega-3 index and BMI (r ¼ 0.146,
p < 0.01) and WC (r ¼ 0.125, p < 0.05). In contrast, no signiﬁcant association between the omega-3
index and anthropometric measures was detected in males. After correcting for the potentially con-
founding effects of age, household income, ﬁsh oil supplement status, daily dietary energy intake and
total physical activity times, the omega-3 index was inversely associated with BMI andWC in females but
not males.
Conclusions: Omega-3 status was associated with weight status, particularly in older women but not in
men. These results suggest the need for sex-based intervention trials to examine the role of dietary
intake and/or supplementation of LCn-3PUFA in weight management of older adults.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Increasing prevalence of overweight and obesity in older adults
heightens the risk of developing and/or aggravating non-ing, University of Newcastle,
(M. Garg).
Inc. This is an open access article ucommunicable illnesses, such as type 2 diabetes (T2D) and car-
diovascular disease (CVD) [1,2]. In 2011e12, 72% of Australian adults
aged 65 years or older were overweight or obese and within the
65e74 years age group, over one in three were obese (35.2%)
compared with approximately one in four in 1995 (24.8%) [3,4]. The
proportion of older adults in Australia is projected to increase from
14% in 2012 to 19% in 2031 and 24% in 2061, and obesity will likely
continue to be a major cause of morbidity and mortality [5].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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terventions, such as increases in physical activity and dietary re-
strictions, and pharmaceutical drug therapy for the morbidly obese.
Excess body fat can limit the ability of older adults to participate in
physical activity, and the long-term use of drugs for long-term
maintenance of weight loss poses potential health risks [6e8].
Diet-induced weight loss can be readily achieved in the short-term
but only a small proportion can sustainweight loss in the long-term
[9,10]. Excess body fat is associated with the accumulation of fat in
adipose tissue as well as elevated levels of pro-inﬂammatory me-
diators which increase the risk of obesity associated inﬂammatory
diseases [8,11,12]. However, excessive weight is preventable, and
therefore safe and efﬁcacious intervention strategies are warranted
to combat obesity and related health issues in older adults.
Long chain omega-3 polyunsaturated fatty acids (LCn-3PUFA),
speciﬁcally eicosapentaenoic acid (EPA; 20:5n-3) and docosahex-
aenoic acid (DHA; 22:6n-3), have the potential to play an important
role in amelioratingmetabolic dysfunction, assisting weight control
and reducing the risk of inﬂammatory disease in older adults [11].
The mechanisms explored in the literature include: (1) increased
fat oxidation and increased thermogenesis, both of which lead to a
decrease in fat deposition in adipose tissue [13]; (2) greater satiety
and suppression of appetite following a LCn-3PUFA rich diet
[14,15]; (3) altered expression of genes involved in regulating lipid
metabolism [13,14,16]; (4) increases in adiponectin (a hormone
synthesised by adipocytes involved in regulating lipid metabolism)
[17]; and (5) facilitation of the synthesis of anti-inﬂammatory ei-
cosanoids (signalling molecules) and inﬂammation resolving
resolvins and protectins (lipid mediators) [11,12,18].
Several animal intervention trials have suggested a role of LCn-
3PUFA in changes to weight status [14,16,19,20] but human studies
have generated conﬂicting results. Most recently, two observational
studies have reported an inverse association between erythrocyte
levels of LCn-3PUFA and body weight status measures [21,22].
Randomised controlled trials have been less convincing, potentially
due to small sample size, the relatively short duration of trials,
varying assessment measures of LCn-3PUFA, and differences in
subject criteria and ﬁsh oil supplementation dosage [23e26].
The omega-3 index reﬂects long-term (over several months),
habitual dietary intake of LCn-3PUFA [27e29]. Therefore, the
omega-3 index is a valid biomarker and measurement tool for
determination of LCn-3PUFA status [22].
The aim of the current study was to examine, for the ﬁrst time in
older adults aged 65 years and over, whether there is an association
between the omega-3 index and measures of body weight status
including body mass index (BMI), waist circumference (WC) and
waist-to-hip ratio (WHR).
2. Subjects and methods
2.1. Subjects and study design
This cross-sectional, observational study included male and fe-
male adults aged 65 years or older from the Retirement Health and
Lifestyle Study (RHLS), a large cross-sectional study of the health
and lifestyle of older adults living on the Central Coast of New South
Wales (NSW), Australia. Participants were eligible for the RHLS if
they: were 65 years of age; their primary residence was located
within the Wyong or Gosford Local Government Areas; and they
had been living at their current address for 12 months. Partici-
pants were not eligible if: they were not living independently or
were residing in a communal setting other than a retirement
village; another member of their household was taking part in the
study; they had language and/or other communicative difﬁculties
that limited participation; or theywere cognitively impaired and/orwere unable to provide informed consent. Eligible participants took
part in an interviewer-administered questionnaire that collected
information relating to subject demographics, medical history,
medications and supplement data, physical activity levels, smoking
status and alcohol consumption. In addition, participants
completed self-administered paper-based questionnaires (food
frequency and additional medical history) and attended a clinic
where fasting blood samples and anthropometric measures were
taken. Participants were included in the present study if they had
erythrocyte samples for the determination of membrane fatty acid
composition.
Written informed consent was obtained from all participants
and the study was approved by the Human Research Ethics Com-
mittee of the University of Newcastle (Reference No. H-2008-0431)
and the Northern Sydney Central Coast Health Human Research
Ethics Committee (Reference No. 1001-031M).
2.2. Biochemical analyses
Fasted (10 h) blood samples were collected by a trained
phlebotomist in accordance with protocol. Blood samples were
centrifuged at 3000  g for 10 min to separate plasma from
erythrocyte fractions. The fatty acid composition of the erythrocyte
cell membranes were determined via direct trans-esteriﬁcation of
the washed erythrocyte fraction followed by standardised gas
chromatographic analyses (GC) [30,31]. A known fatty acid mixture
was used to compare with analysed samples to identify peaks ac-
cording to retention time and their concentration was determined
using a Hewlett Packard 6890 Series GC with Chemstations Version
A. 04.02 software. The omega-3 index was determined by summing
erythrocyte membrane EPA and DHA expressed as a percentage of
total erythrocyte fatty acids (%EPA plus %DHA).
2.3. Anthropometric measurements
Anthropometric measurements including height, weight, WC
and hip circumference (HC), were taken by research project ofﬁcers
according to World Health Organisation (WHO) recommendations
[32]. Weight was measured using calibrated standardised portable
digital scales (Tanita HD-316, Tanita Corporation, Tokyo, Japan; or
Wedderburn UWPM150, Wedderburn Scales, Australia). Two
weight measurements were taken to the nearest 100 g to calculate
a mean weight. Height was measured using a portable stadiometer
(design no. 1013522, Surgical and Medical Products, Australia). Two
height measurements were taken to the nearest 0.1 cm to calculate
a mean height. For both weight and height measurements, partic-
ipants were required to remove shoes and any heavy items of
clothing or heavy objects from pockets. Mean weight and height
were used to calculate BMI (non-obese< 0 kg/m2, obese30 kg/m2).
WC and HC were measured using a stretch resistant, ﬂexible tape.
Two measurements were taken to the nearest 0.1 cm to calculate
the mean values. WC was measured at the midway point between
the lowest rib and iliac crest; HC was taken at the greatest posterior
protuberance of the buttocks. Mean WC and HC were used to
determine a WHR. For all anthropometric measures, if the two
measurements varied more than the set tolerances of 800 g for
weight, 1 cm for height, and 2 cm for WC and HC measurements
were repeated until two measurements were within protocol.
Health risk categories for both WC and WHR are based on current
Australian guidelines [7,33,34]. In relation to WC, the guidelines
indicate that adults are at increased disease risk if WC94 cm (for
males) or WC80 cm (for females), or at greatly increased risk if
WC102 cm (for males) or WC88 cm (for females) [7,34]. For
WHR, adults are at increased disease risk if WHR>0.9 (for males)
and WHR>0.8 (for females) [33,34].
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Physical activity was assessed via a series of questions that were
adapted from validated questionnaires; the Active Australia Survey
[35], RESIDE's Neighbourhood Physical Activity Questionnaire [36],
the International Physical Activity Questionnaire [37], and the
AusDiab General Questionnaire 04/05 [38]. Questions assessed
levels of physical activity in the week prior to study participation.
The frequency and duration of walking, moderate physical activity
and vigorous physical activity were assessed. Total activity time
was calculated by summing the time spent walking continuously
for durations of 10 min or more with the time spent in moderate
activity and twice the time spent in vigorous activity (not including
gardening and yard work) [35].
2.5. Dietary intake and ﬁsh oil supplementation assessment
A self-administered food frequency questionnaire (FFQ) was
adapted from the validated Commonwealth Scientiﬁc and Indus-
trial Research Organisation (CSIRO) FFQ [39] and included 41
questions regarding usual dietary intake. Dietary intake data were
analysed using Foodworks®Professional Edition 2009 Version
6.0.2562 (Xyris Software, Brisbane, Queensland, Australia) [40].
2.6. Statistical analysis
Study data were analysed using Statistical Package for the Social
Sciences (SPSS; Release 22.0, Chicago, IL: SPSS Inc.). Data distribu-
tions were evaluated for normality, linearity and homoscedascity.
Erythrocyte membrane fatty acid data were arcsine transformed
and total activity time data was log transformed before analyses.
Data are reported as the mean ± standard deviation (SD) or fre-
quencies and percentage, as appropriate. Groups were compared
using two-tailed chi-square analyses, independent sample t-tests
and one-way ANOVA. Standard multiple regression analyses were
used to assess the multivariate relationships between the omega-3
index and body weight status measures (BMI, WC and WHR) after
correcting for the potentially confounding effects of age, household
income, ﬁsh oil supplement status, daily energy intake and total
activity time. Pearson productemoment correlation analyses were
used to assess the bivariate relationships between variables.
Separate correlation analyses were performed for male and female
participants. Male and female participants were categorised into
omega-3 index quartiles according to sex-speciﬁc omega-3 index
quartile cut-offs. Differences in mean BMI, WC and WHR across
omega-3 index quartiles were assessed using one-way ANOVA.
Probability values of <0.05 were considered statistically signiﬁcant.
3. Results
3.1. Participant characteristics
Participant characteristics for age, socio-demographic, ﬁsh oil
supplement and hormone replacement therapy (HRT) use and
physical activity levels are presented in Table 1 for the whole group
and for male and female subgroups. The study population included
620 participants (females 56.3%) aged 65e95 years (mean
77.6 ± 6.9 years). There was no signiﬁcant difference in mean age
between males and females. Six hundred and ﬁve participants (267
males, 338 females) provided an estimate of their household in-
come. Over ninety percent of participants reported household in-
comes of between $10,000 and $60,000, with the majority of these
reporting household incomes between $10,000 and $40,000
(Table 1). Gender differences in the proportion of participants
within each income bracket were found with a signiﬁcantly higherproportion of females reporting household incomes of between
$10,000 to $20,000, and a signiﬁcantly lower proportion of females
reporting household incomes of between $20,000 and $40,000,
when compared to males (Table 1).
One hundred and sixty nine study participants reported taking
ﬁsh oil supplements (62 males, 107 females; Table 1). Three hun-
dred and seven female participants provided information regarding
HRT use. Of these, 59.0% reported no history of HRT use, 12.4% re-
ported they were currently using HRT and 28.7% reported taking
HRT previously.
Study participants reported spending an average of 190.4 min in
physical activity over the seven days prior to study participation,
with the total time spent ranging from 0 to 1620 min (Table 1). The
mean total activity time differed between males and females, with
males reporting signiﬁcantly higher total activity times than fe-
males. Male participants also reported a signiﬁcantly higher mean
daily energy intake when compared to female participants
(Table 1).
Participant anthropometric characteristics for the whole group
and the gender subgroups are presented in Table 2. The mean
weight and height of male participants was signiﬁcantly higher
than female participants; however BMI was not signiﬁcantly
different between the two groups. According to BMI, 2.6% of the
whole group were morbidly obese (BMI40 kg/m2), 31.9% were
obese (BMI30 kg/m2), 42.7% were overweight (BMI 25e29.9 kg/
m2), 22.1% were healthy weight (BMI 18.5e24.9 kg/m2) and 0.7%
were underweight (BMI<18.5 kg/m2). There was no signiﬁcant
difference in the proportion of males and females within each BMI
category (Table 2).
The WC andWHR of male participants were signiﬁcantly higher
than female participants while the HC was not signiﬁcantly
different (Table 2). Based on current Australian guidelines to
identify disease risk using abdominal adiposity measurements (WC
and WHR), at least 82.8% of participants were either at increased
risk or greatly increased risk of disease [7,34].
3.2. Erythrocyte fatty acids
Erythrocyte membrane fatty acid proﬁles were signiﬁcantly
different for male and female participants for total mono-
unsaturated fatty acids (MUFA) and total polyunsaturated fatty
acids (PUFA) but not total saturated fatty acids (SFA) (Table 3). Total
erythrocyte membrane omega-6 PUFA was signiﬁcantly lower in
female participants compared with male participants but the
reverse was true for total MUFA and total omega-3 PUFA, which
were both signiﬁcantly higher in female participants compared
with male participants (Table 3).
With regards to LCn-3PUFA, mean erythrocyte docosapentae-
noic acid (DPA; 22:5n-3) did not differ between male and females;
however females had signiﬁcantly higher EPA and DHA, and
consequently higher omega-3 index scores, than male participants
(Table 3).
When male and females groups were stratiﬁed as obese or non-
obese, based on BMI, the omega-3 index of non-obese female
participants was signiﬁcantly higher than that of obese female
participants (p< 0.05) (Fig.1). Therewas no signiﬁcant difference in
omega-3 index between non-obese and obese male participants.
The results of bivariate correlation analyses of the relationships
between erythrocyte omega-3 PUFA and anthropometric measures
are presented in Table 4. When all participants were included in the
analyses an inverse association between the omega-3 index and
anthropometric measures, BMI (r ¼ 0.076, p ¼ 0.06), WC
(r ¼ 0.118, p < 0.01) and WHR (r ¼ 0.149, p < 0.001) was
observed. However, stratiﬁcation of participants on sex indicated
that these associations were gender speciﬁc (Table 4).
Table 1
Age, socio-demographic, ﬁsh oil supplement and hormone replacement therapy use and physical activity characteristics of study participantsb.
Whole group Males Females p-value
Number of subjects 620 271 (43.7) 349 (56.3)
Age (years), mean ± SD 77.6 ± 6.9 77.3 ± 6.7 78.0 ± 7.1 ns
Annual household income
Less than $10,000 4 (0.7) 0 (0.0) 4 (1.2)
$10,000 to $20,000 201 (33.2) 44 (16.5) 157 (46.4)
$20,000 to $40,000 292 (48.3) 159 (59.6) 133 (39.3)
$40,000 to $60,000 66 (10.9) 39 (14.6) 27 (8.0)
$60,000 to $80,000 23 (3.8) 15 (5.6) 8 (2.4)
$80,000 to $100,000 13 (2.1) 7 (2.6) 6 (1.8)
$100,000 or more 6 (1.0) 3 (1.1) 3 (0.9) <0.001
Fish oil supplement use
Non-supplemented 451 (72.7) 209 (77.1) 242 (69.3)
Supplemented 169 (27.3) 62 (22.9) 107 (30.7) <0.05
Hormone replacement therapy use
No history N/A N/A 181 (59.0)
Previous history N/A N/A 88 (28.7)
Current N/A N/A 38 (12.4)
Dietary energy intake
Daily energy (kJ), mean ± SD 8041 ± 3107 8451 ± 3035 7723 ± 3129 <0.01
Physical activitya
Total activity (mins), mean ± SD 190.4 ± 255.5 255.2 ± 295.8 140.3 ± 206.2 <0.001
a Total activity timewas calculated by summing the time spent walking continuously for durations of 10min or more with the time spent inmoderate activity and twice the
time spent in vigorous activity (not including gardening and yard work) over the 7 days prior to study participation.
b Data presented as frequency counts (percentage) unless otherwise indicated. Frequency counts and sample means were compared across male and female sub-groups
using two-tailed chi-square analyses and independent samples t tests, respectively. For a number of parameters, subject numbers were reduced due to missing data.
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3 index and BMI (r¼0.146, p< 0.01) andWC (r¼0.125, p< 0.05)
in females participants (Table 4). Analyses of the relationship be-
tween the omega-3 index component fatty acids, DHA and EPA, and
the anthropometric variables indicated that these relationships
primarily reﬂected female-speciﬁc inverse associations between
DHA and body weight status. In females, DHA was inversely asso-
ciatedwith BMI (r¼0.157, p < 0.01), WC (r¼0.142, p < 0.01) and
WHR (r ¼ 0.143, p < 0.01), however, no relationship was detected
between EPA and BMI, WC or WHR. In contrast, there was no sig-
niﬁcant association between the omega-3 index, or DHA or EPA,
and any of the anthropometric measures in the male subgroup
(Table 4).
Multiple regression analyses were conducted to assess the as-
sociation between omega-3 index and the anthropometric vari-
ables, BMI, WC and WHR after adjusting for the potentially
confounding variables; age, household income, ﬁsh oil supplement
status, daily dietary energy intake and total physical activity times.
The multivariate relationships between omega-3 index and each
anthropometric measure were assessed separately and the results
are summarised in Table 5. When combined in a multivariate
analysis, age, household income, supplement status, daily energy
intake, total physical activity time and omega-3 index were able toTable 2
Anthropometric characteristics of study participantsb.
Whole group (n ¼ 620)
Anthropometric measures
Weight (kg) 76.2 ± 15.4
Height (m) 1.63 ± 0.09
BMI (kg/m2)a 28.6 ± 4.8
Morbidly obese, n (%) 16 (2.6)
Obese, n (%) 195 (31.9)
Overweight, n (%) 261 (42.7)
Health weight, n (%) 135 (22.1)
Underweight, n (%) 4 (0.7)
WC (cm) 98.8 ± 13.6
HC (cm) 109.3 ± 10.5
WHR 0.90 ± 0.08
a BMI categories deﬁned as: Obese, BMI30 kg/m2; Overweight, BMI 25e29.9 kg/m2;
b Data presented as mean ± SD unless otherwise indicated. Sample means and frequ
independent samples t tests and chi-square analyses, respectively.signiﬁcantly predict BMI and WC in both males and females, and
WHR in females. However, consistent with the bivariate ﬁndings,
gender speciﬁcity in the relationships between anthropometric
variables and omega-3 index was observed, with omega-3 index
displaying an independent associationwith BMI andWC in females
(BMI: b¼0.167, p < 0.01;WC: b¼0.144, p < 0.05) but not males.
Themean (±SD) BMI,WC andWHR scores for males and females
sub-grouped into quartiles on the basis of their omega-3 index
scores are presented in Table 6, together with the results of one-
way ANOVA of group differences. In males, no signiﬁcant group
differences, or trends in the magnitude of the quartile means, were
evident for BMI, WC or WHR. Similarly, no signiﬁcant group dif-
ferences in mean BMI or WC were detected across the female
omega-3 index quartiles subgroups. However, BMI did decrease
with increasing omega-3 index quartiles (p ¼ 0.078). Differences in
mean WHR were also detected in females (p < 0.05) reﬂecting a
signiﬁcant reduction in the mean WHR of participants in quartile 4
when compared to those in quartile 2 (p < 0.05).
No signiﬁcant association was detected between the omega-3
index and participant's household income or daily energy intake
(data not reported). There was also no signiﬁcant association be-
tween HRT use and the omega-3 index or any of the individual LCn-
3PUFA (EPA, DPA and DHA). A positive association between omega-Males (n ¼ 271) Females (n ¼ 349) p-value
83.5 ± 14.9 70.5 ± 13.2 <0.001
1.71 ± 0.07 1.57 ± 0.06 <0.001
28.6 ± 4.5 28.6 ± 5.1 ns
4 (1.5) 12 (3.5)
87 (32.6) 108 (31.4)
125 (46.8) 136 (39.5)
49 (18.4) 86 (25.0)
2 (0.7) 2 (0.6) ns
104.9 ± 12.5 94.0 ± 12.4 <0.001
108.6 ± 9.1 109.8 ± 11.3 ns
0.96 ± 0.07 0.86 ± 0.06 <0.001
Healthy weight, BMI 18.5e24.9 kg/m2; Underweight, BMI<18.5 kg/m2.
ency counts were compared across male and female sub-groups using two-tailed
Table 3
Erythrocyte fatty acid composition (% wt/wt) of study participantsa.
Whole group (n ¼ 620) Males (n ¼ 271) Females (n ¼ 349) p-value
Saturated fatty acids (SFA)
C16:0 22.9 ± 1.3 22.9 ± 1.3 22.8 ± 1.2 ns
C18:0 18.4 ± 1.5 18.4 ± 1.5 18.6 ± 1.3 ns
C20:0 0.6 ± 0.4 0.6 ± 0.4 0.6 ± 0.1 <0.05
∑SFA 41.9 ± 2.3 41.9 ± 2.3 42.0 ± 2.0 ns
Monounsaturated fatty acids (MUFA)
C16:1n-7 0.5 ± 0.3 0.5 ± 0.3 0.6 ± 0.3 <0.01
C18:1n-7 1.7 ± 0.4 1.7 ± 0.4 1.8 ± 0.4 ns
∑MUFA 2.3 ± 0.5 2.3 ± 0.5 2.4 ± 0.6 <0.01
Polyunsaturated fatty acids (PUFA)
C18:2n-6 8.9 ± 1.5 8.9 ± 1.5 8.7 ± 1.5 ns
C18:3n-6 0.2 ± 0.2 0.2 ± 0.2 0.2 ± 0.2 ns
C20:2n-6 0.3 ± 0.3 0.3 ± 0.3 0.3 ± 0.1 <0.001
C20:3n-6 1.6 ± 1.2 1.6 ± 1.2 1.4 ± 1.1 <0.05
C20:4n-6 16.7 ± 2.5 16.7 ± 2.5 16.6 ± 2.5 ns
∑n-6 PUFA 27.7 ± 2.6 27.7 ± 2.6 27.2 ± 2.7 <0.05
C18:3n-3 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 ns
C20:5n-3 (EPA) 1.5 ± 0.8 1.5 ± 0.8 1.9 ± 1.2 <0.001
C22:5n-3 (DPA) 3.6 ± 0.7 3.6 ± 0.7 3.6 ± 0.8 ns
C22:6n-3 (DHA) 6.5 ± 1.4 6.5 ± 1.4 6.9 ± 1.4 <0.001
∑n-3 PUFA 11.9 ± 2.5 11.9 ± 2.5 12.6 ± 2.8 <0.001
Omega-3 index 8.0 ± 2.1 8.0 ± 2.1 8.8 ± 2.4 <0.001
∑LCn-3 PUFA 11.6 ± 2.5 11.6 ± 2.5 12.4 ± 2.9 <0.001
a Data presented as mean ± SD. Sample means were compared across male and female sub-groups using two-tailed independent samples t tests of the arcsine transformed
fatty acid data.
Fig. 1. Mean omega-3 index scores based on weight status in male and female sub-
groups. The omega-3 index of non-obese (BMI < 30 kg/m2) female participants
(9.0% ± 2.5) was signiﬁcantly higher than obese (BMI  30 kg/m2) female participants
(8.4% ± 2.2) (p < 0.05).
Table 4
Correlations between long chain omega-3 PUFA and anthropometric
measurementsa.
Whole group
(n ¼ 620)
Males (n ¼ 271) Females (n ¼ 349)
r p-value r p-value r p-value
EPA
BMI 0.077 ns 0.026 ns 0.105 ns
WC 0.121 <0.01 0.054 ns 0.083 ns
WHR 0.119 <0.01 0.032 ns 0.039 ns
DHA
BMI 0.064 ns 0.068 ns 0.157 <0.01
WC 0.100 <0.05 0.076 ns 0.142 <0.01
WHR 0.147 <0.001 0.032 ns 0.143 <0.01
Omega-3 index
BMI 0.076 ns 0.037 ns 0.146 <0.01
WC 0.118 <0.01 0.031 ns 0.125 <0.05
WHR 0.149 <0.001 0.008 ns 0.106 ns
∑LCn-3PUFA
BMI 0.097 <0.05 0.009 ns 0.152 <0.01
WC 0.126 <0.01 0.027 ns 0.125 <0.05
WHR 0.136 <0.001 0.031 ns 0.100 ns
a Data presented as Pearson's correlation coefﬁcient (r). Bivariate correlation
analyses were conducted using Pearson's product-moment correlation of the
arcsine transformed n-3 PUFA data against the anthropometric measures.
E. Mingay et al. / Journal of Nutrition & Intermediary Metabolism 5 (2016) 70e77743 index levels and total physical activity time was found (R ¼ 0.091,
p < 0.05). As expected, participants taking ﬁsh oil supplements had
a higher omega-3 index (10.3 ± 2.1%) than non-supplemented
participants (7.8 ± 1.9%, p < 0.001).
4. Discussion
This cross-sectional study suggests an inverse association be-
tween the omega-3 index and all anthropometric measures (BMI,
WC and WHR) in older Australians. Stratiﬁcation of the study
cohort on gender highlighted that this association is only evident in
females and not in males.
Relevant to this report is a unique set of characteristics that face
the older adult population, including increased prevalence of
obesity, an ageing demographic, the physiological and biological
changes associated with ageing including compromised immunity,reduced lean muscle mass, reduced appetite and level of physical
activity, and redistribution of fat towards visceral rather than
subcutaneous adipose tissue [8,43]. The study highlighted that over
one third (39.3%) of the participants aged 65e74 years were obese
which is in line with the Australian Health Survey 2011e2012 that
indicated that within the 65e74 year group 35.2%were obese [3]. In
addition, based on abdominal adiposity measurements (WC and
WHR), over 82% of participants were identiﬁed at increased health
risk according to current Australian guidelines [7,34]. Abdominal
obesity in older adults places them at increased risk of adverse
metabolic consequences and susceptibility to co-morbidities
including T2D, metabolic syndrome, CVD and arthritis [43].
While this is the ﬁrst study to examine whether an association
exists between LCn-3PUFA levels and body weight status in an
Table 5
Multiple regression analyses of the relationship between omega-3 index [41,42] and
the anthropometric variables, BMI, waist circumference and waist to hip ratio after
controlling for potential covariatesa.
Males Females
BMI
Model statistics R¼ 0.328, R2¼ 0.108 R¼ 0.356, R2¼ 0.126
F (6,254) ¼ 5.107,
p < 0.001
F (6,326) ¼ 7.863,
p < 0.001
Variables b p b p
Age 0.211 <0.01 0.217 <0.001
Household income 0.040 ns 0.171 <0.01
Fish oil supplement 0.045 ns 0.099 ns
Daily energy intake 0.035 ns 0.003 ns
Total activity time 0.258 <0.001 0.215 <0.001
Omega-3 index 0.106 ns 0.167 <0.01
Waist circumference
Model statistics R¼ 0.326, R2¼ 0.106 R¼ 0.307, R2¼ 0.094
F (6,255) ¼ 5.060,
p < 0.001
F (6,329) ¼ 5.704,
p < 0.001
Variables b p b p
Age 0.169 <0.01 0.139 <0.05
Household income 0.046 ns 0.109 ns
Fish oil supplement 0.025 ns 0.111 ns
Daily energy intake 0.018 ns 0.022 ns
Total activity time 0.288 <0.001 0.226 <0.001
Omega-3 index 0.103 ns 0.144 <0.05
Waist:Hip ratio
Model statistics R¼ 0.217, R2¼ 0.047 R¼ 0.205, R2¼ 0.042
F (6,254) ¼ 2.099,
p ¼ 0.054
F (6,327) ¼ 2.398,
p < 0.05
Variables b p b p
Age 0.117 ns 0.031 ns
Household income 0.090 ns 0.065 ns
Fish oil supplement 0.040 ns 0.069 ns
Daily energy intake 0.032 ns 0.019 ns
Total activity time 0.169 <0.01 0.133 <0.05
Omega-3 index 0.070 ns 0.114 ns
a Multiple regression analyses were conducted using the log transformed total
physical activity data and arcsine transformed omega-3 index data. Total activity
time (minutes) was calculated by summing the time spent walking continuously for
durations of 10 min or more with the time spent in moderate activity and twice the
time spent in vigorous activity (not including gardening and yard work) over the 7
days prior to study participation.
Table 6
Comparison of anthropometric characteristics for male and female participants
across omega-3 index quartilesa.
Omega-3 index quartile p-value
1 2 3 4
BMI (kg/m2)
Males 28.4 ± 4.7 27.9 ± 4.2 29.8 ± 4.6 28.5 ± 4.2 0.074
Females 29.4 ± 5.3 29.1 ± 5.1 28.3 ± 4.8 27.6 ± 5.0 0.078
WC (cm)
Males 104.2 ± 13.5 102.9 ± 10.7 108.3 ± 13.5 104.3 ± 11.8 0.065
Females 95.1 ± 13.0 96.3 ± 12.6 92.7 ± 11.4 91.9 ± 12.0 0.061
WHR
Males 0.97 ± 0.08 0.96 ± 0.06 0.97 ± 0.05 0.96 ± 0.06 0.980
Females 0.85 ± 0.06 0.87 ± 0.06 0.85 ± 0.06 0.84 ± 0.06 0.042
a Data presented asmean ± SD. p values are for the comparison of anthropometric
variables across quartiles using one-way ANOVA. Participants were assigned into
omega-3 index quartiles on the basis of their omega-3 index score separately for
males and females. Increasing omega-3 index quartile numbers reﬂect increasing
omega-3 index scores.
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explored the possible association in adults, children and adoles-
cents with consistent results in most cases [21,22,44e46]. Where
conﬂicting results have been reported, variations in study design;
sample size; study duration and the methodologies used to quan-
titate LCn-3PUFA, which have included investigation of dietaryintake (using dietary food records and food frequency question-
naires) and analysis of plasma total lipids, plasma phospholipids or
erythrocyte biomarkers, may have contributed.
Most recently in an observational study, Howe et al. [22]
explored the association between erythrocyte levels of LCn-
3PUFA and obesity in adults aged 34e60 years (n ¼ 476). Consis-
tent with the current ﬁndings, Howe et al. found an inverse asso-
ciation between erythrocyte LCn-3PUFA levels and adiposity (BMI,
WC and body fat) that was evident in females but not males [22]. In
addition, it was speciﬁcally DHA, and not EPA, that displayed the
strongest association [22]. Harris et al. [21] analysed a larger cohort
(n ¼ 3196) from the Framingham Heart Study and reported an in-
verse association between erythrocyte LCn-3PUFA levels and WC,
the sole body weight status measure included in that study [21].
Three smaller studies (n ¼ 124 adults, n ¼ 120 adolescents and
n ¼ 48 children) reported the same inverse association between
erythrocyte or plasma LCn-3PUFA levels and varying anthropo-
metric measures [44e46].
Conﬂicting results were reported in two large cohort studies
that explored the relationship between dietary intake of LCn-
3PUFA and overweight and obesity. The Health Professional
Follow-up Study (n ¼ 43,671 men) reported that dietary intake of
LCn-3PUFA was associated with healthier weight status [47].
However, the Nurses' Health Study (n ¼ 79,839 women) showed a
positive association between higher intake of LCn-3PUFA and
obesity prevalence [48]. While the possibility that gender differ-
ences could explain the contradictory results, both studies relied
solely on FFQ data to estimate dietary intake of LCn-3PUFA.
Research indicates that fatty acid biomarkers (in plasma or
erythrocyte membrane) are more accurate estimates of habitual
dietary intake of fatty acids compared with questionnaire-based
estimates and therefore are more reliable for assessment of asso-
ciations with body weight status measures [22]. Of the two,
erythrocyte fatty acids are considered to be the more superior
marker as they reﬂect long-term dietary intake of fatty acids
[27,29,49].
The gender differences in the current study support previous
indications that fatty acid metabolism may be different in females
compared with males due to the effects of sex hormones .[50, 51]
_ENREF_48 Previous studies have indicated that conversion of a-
linolenic (ALA) to DHA is mediated by the oestrogen hormone
which enhances the capacity of females to synthesise DHA from
ALA [52e55]. This may not be relevant to the current study as the
female population group are post-menopausal and >65 years.
However, female subjects may still have higher circulating oes-
trogen levels than male counterparts that inﬂuence levels of DHA
and the omega-3 index; and there is some evidence to suggest that
in females of post-menopausal age, HRT reduces the retro-
conversion of DHA to EPA [56]. However, in the current study we
found no signiﬁcant association between HRT use and levels of the
LCn-3PUFA, including EPA and DHA. A recent study has shown that
ingestion of ALA rich chia seeds resulted in signiﬁcant increases in
plasma EPA levels in post-menopausal women [57]. It is also
possible that women have a lower capacity than men to retro-
convert DHA to DPA and EPA [51]. Previous evidence does suggest
that circulating LCn-3PUFA levels, and the omega-3 index, may not
be solely determined by the amount of preformed EPA and/or DHA
consumed in the diet, particularly for female participants [51].
Further investigation into the differences betweenmale and female
omega-3 index levels is beyond the scope of this report.
Several animal intervention trials have reported a reduction in
body fat accumulation, particularly a reduction in visceral adipose
tissue compared to subcutaneous adipose tissue, following high fat
diets that included LCn-3PUFA [14,16,19,20]. These animal studies
were all conducted in male rodents and therefore do not shed any
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relating to the potential effects of LCn-3PUFA on the deposition of
fat in adipose tissue.
The human intervention trials that have explored the effects of
increased intake of LCn-3PUFA on body weight status have gener-
ated conﬂicting results. The studies varied in sample size (n ¼ 6 to
278), duration (6e24 weeks), subject characteristics (sex, age,
health status), style of intervention, dietary-restriction regimes and
doses of ﬁsh oil supplementation. Most recently, Harden et al. [23]
conducted a double-blind, randomised, parallel intervention trial
over 12 weeks and reported signiﬁcantly lower energy intake,
indicating the potential appetite suppressing effects of LCn-3PUFA.
A fall in body weight approached statistical signiﬁcance suggesting
the need for a longer term study. Munro and Garg [25] conducted a
double-blind randomised, placebo controlled intervention and
demonstrated a greater percentage reduction inweight and BMI for
females in the ﬁsh oil supplementation group compared to control.
In an earlier study, Thorsdottir et al. [26] explored the effects of
ﬁsh consumption and ﬁsh oil supplementation as part of an energy-
restricted diet in an overweight adult population. Greatest weight
loss was evident inmales who included ﬁsh or ﬁsh oil supplements,
but not females. This study provides conﬂicting results surrounding
gender differences but the short duration of the trial (eight weeks)
limits the conclusions that can be drawn. Krebs et al. [24] also found
similar results in an overweight, insulin-resistant female adult
population (n ¼ 93; aged 21e69 years) on a low fat/high carbo-
hydrate weight-loss program with ﬁsh oil supplements. While this
study provided no evidence of increased weight loss from inclusion
of ﬁsh oil compared with placebo oil, it was recognised that the low
fat/high carbohydrate diet could affect the provision of essential
LCn-3PUFA from food sources, thereby potentially counteracting
some beneﬁt from ﬁsh oil supplementation [24].
It is recognised that body weight status is also affected by other
lifestyle behaviours which could explain conﬂicting and/or the
varying strength of associations in previous research. These could
include the amount and intensity of physical activity, quality of diet
and existing disease states. Physical activity for the older adult
population, in the form of some aerobic plus resistance training, is
beneﬁcial for improving and/or maintaining physical function and
muscle mass, and promotes independent living and quality of life
[8]. The current study did not explore speciﬁc exercise activities of
participants, but rather examined the total amount of time spent in
physical activity.
Studies that examined increased intake of LCn-3PUFA with an
exercise regime to assess effect on body weight status are limited
and have conﬂicting results. Varying study design, outcome mea-
sures, participant baseline metabolic abnormalities and baseline fat
mass may have contributed to this conﬂict. A more recent rando-
mised control trial of the status of sedentary, overweight and obese
adults over 24 weeks indicated no additional beneﬁt of LCn-3PUFA
supplementation, compared to a diet and exercise based weight
loss program [58]. In contrast, Hill et al. [59] found reductions in
body fat in a randomised control trial of overweight and obese
adults with a combined intervention of LCn-3PUFA supplementa-
tion with a moderate-intensity exercise regime.
The small signiﬁcant association in the current study does not
indicate a causal relationship between LCn-3PUFA and body weight
status but it does suggest the potential role of LCn-3PUFA to assist
weight loss and/or weight gain when used in conjunction with
appropriate dietary and physical activity strategies for the older
adult population, particularly inwomen. Obesity is characterised as
a condition with chronic low-grade inﬂammation and the anti-
inﬂammatory properties of LCn-3PUFA are well recognised. The
potential role of LCn-3PUFA to increase fatty acid oxidation to assist
with weight control, ameliorate metabolic dysfunction andmodulate inﬂammatory processes warrants further investigation.
The current study was strengthened by its large sample size of
participants that were randomly selected and representative of the
most recent trend of obesity among Australian older adults as re-
ported in the Australian Health Survey [3]. The omega-3 index is a
reliable, valid biomarker used to explore the relationship between
LCn-3PUFA and body weight status and reﬂects intake over several
months. While DPA is excluded from the determination of the
omega-3 index, this study did consider DPA during analysis of the
data (as part of total LCn-3PUFA); however there was very little
difference in the association between anthropometric measures
and total LCn-3PUFA versus the omega-3 index (data not reported).
The limitations of the current study include a lack of body
composition data to compliment body weight status measures. The
cross-sectional study design used data collected by the RHLS which
included varying levels of ﬁsh oil supplementation and physical
activity. It is acknowledged that the correlation coefﬁcients are
small, and that while statistically signiﬁcant, the relationship be-
tween LCn-3PUFA and the anthropometrics characteristics may not
be sufﬁcient to contribute signiﬁcantly to weight control in a clin-
ical setting when used in isolation. However, research investigating
the interactive effects of high dietary or supplemental intakes of
LCn-3PUFA on weight reduction when used in isolation or in as-
sociation with other weight loss methods in older populations is
limited. The current study has identiﬁed an association between
LCn-3PUFA and body weight status in elderly participants and in-
dicates the need for further research regarding the clinical signiﬁ-
cance of these ﬁndings in assisting weight reduction in this age
group.
In conclusion, the results indicate that omega-3 index was
inversely associated with weight status in females, but not males.
Mainstream strategies for treatment of overweight and obesity are
not necessarily appropriate for this vulnerable population group
and the results warrant future longer-term intervention trials to
examine the role of increased intake of LCn-3PUFA via food sources
and/or supplementation in weight management of older adults.
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